Cleared Traditional

K121075 - NERVEVISION SOFTWARE SYSTEMS

K121075 is an FDA 510(k) clearance for NERVEVISION SOFTWARE SYSTEMS, manufactured by 3D Imaging Partners, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 108-day FDA review.

K121075 · 3D Imaging Partners, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2012
Decision
108d
Days
Class 2
Risk

K121075 is an FDA 510(k) clearance for the NERVEVISION SOFTWARE SYSTEMS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by 3D Imaging Partners, Inc. (Bradenton, US). The FDA issued a Cleared decision on July 26, 2012 after a review of 108 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all 3D Imaging Partners, Inc. devices

FDA 510(k) Submission Details - K121075

510(k) Number K121075 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 09, 2012
Decision Date July 26, 2012
Days to Decision 108 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
1d slower than avg
Panel avg: 107d · This submission: 108d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1270
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K121075.
MR VESSELLQ XPRESS
K122164 · GE Medical Systems SCS · Sep 2012
8MP COLOR LCD MONITOR, REDIFORCE RX840
K120451 · Eizo Nanao Corporation · Aug 2012
DYNAPBV BODY SOFTWARE
K121292 · Siemens Medical Solutions USA, Inc. · Jul 2012
NIO 5MP
K121788 · Barco N.V. · Jul 2012
3MP COLOR LCD MONITOR, RADIFORCE RX340
K113562 · Eizo Nanao Corporation · Jul 2012
SYNAPSE 3D CARDIAC TOOLS
K120636 · Fujifilm Medical System U.S.A., Inc. · Jul 2012